These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 19906454)

  • 1. High-dose erythropoietin in patients with acute myocardial infarction: a pilot, randomised, placebo-controlled study.
    Ferrario M; Arbustini E; Massa M; Rosti V; Marziliano N; Raineri C; Campanelli R; Bertoletti A; De Ferrari GM; Klersy C; Angoli L; Bramucci E; Marinoni B; Ferlini M; Moretti E; Raisaro A; Repetto A; Schwartz PJ; Tavazzi L
    Int J Cardiol; 2011 Feb; 147(1):124-31. PubMed ID: 19906454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early haemoglobin-independent increase of plasma erythropoietin levels in patients with acute myocardial infarction.
    Ferrario M; Massa M; Rosti V; Campanelli R; Ferlini M; Marinoni B; De Ferrari GM; Meli V; De Amici M; Repetto A; Verri A; Bramucci E; Tavazzi L
    Eur Heart J; 2007 Aug; 28(15):1805-13. PubMed ID: 17412728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythropoietin prevention trial of coronary restenosis and cardiac remodeling after ST-elevated acute myocardial infarction (EPOC-AMI): a pilot, randomized, placebo-controlled study.
    Taniguchi N; Nakamura T; Sawada T; Matsubara K; Furukawa K; Hadase M; Nakahara Y; Nakamura T; Matsubara H
    Circ J; 2010 Nov; 74(11):2365-71. PubMed ID: 20834185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and feasibility of adjunctive antiplatelet therapy with intravenous elinogrel, a direct-acting and reversible P2Y12 ADP-receptor antagonist, before primary percutaneous intervention in patients with ST-elevation myocardial infarction: the Early Rapid ReversAl of platelet thromboSis with intravenous Elinogrel before PCI to optimize reperfusion in acute Myocardial Infarction (ERASE MI) pilot trial.
    Berger JS; Roe MT; Gibson CM; Kilaru R; Green CL; Melton L; Blankenship JD; Metzger DC; Granger CB; Gretler DD; Grines CL; Huber K; Zeymer U; Buszman P; Harrington RA; Armstrong PW
    Am Heart J; 2009 Dec; 158(6):998-1004.e1. PubMed ID: 19958867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: Evaluation of MCC-135 for left ventricular salvage in acute myocardial infarction (EVOLVE).
    Jang IK; Weissman NJ; Picard MH; Zile MR; Pettigrew V; Shen S; Tatsuno J; Hibberd MG; Tzivoni D; Wackers FJ;
    Am Heart J; 2008 Jan; 155(1):113.e1-8. PubMed ID: 18082500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and rationale of low-dose erythropoietin in patients with ST-segment elevation myocardial infarction (EPO-AMI-II study): a randomized controlled clinical trial.
    Minamino T; Toba K; Higo S; Nakatani D; Hikoso S; Umegaki M; Yamamoto K; Sawa Y; Aizawa Y; Komuro I;
    Cardiovasc Drugs Ther; 2012 Oct; 26(5):409-16. PubMed ID: 22940818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of erythropoietin as an adjunct to primary percutaneous coronary intervention: a randomised controlled clinical trial.
    Ludman AJ; Yellon DM; Hasleton J; Ariti C; Babu GG; Boston-Griffiths E; Venugopal V; Walker M; Holdright D; Swanton H; Crake T; Brull D; Moon JC; Puranik R; Muthurangu V; Taylor A; Hausenloy DJ
    Heart; 2011 Oct; 97(19):1560-5. PubMed ID: 21900585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High serum erythropoietin level is associated with smaller infarct size in patients with acute myocardial infarction who undergo successful primary percutaneous coronary intervention.
    Namiuchi S; Kagaya Y; Ohta J; Shiba N; Sugi M; Oikawa M; Kunii H; Yamao H; Komatsu N; Yui M; Tada H; Sakuma M; Watanabe J; Ichihara T; Shirato K
    J Am Coll Cardiol; 2005 May; 45(9):1406-12. PubMed ID: 15862410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined VEGF gene transfer and erythropoietin in ovine reperfused myocardial infarction.
    Olea FD; De Lorenzi A; Cortés C; Cuniberti L; Fazzi L; Flamenco Mdel P; Locatelli P; Cabeza Meckert P; Bercovich A; Laguens R; Crottogini A
    Int J Cardiol; 2013 May; 165(2):291-8. PubMed ID: 21944383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and feasibility of combined granulocyte colony stimulating factor and erythropoetin based-stem cell therapy using intracoronary infusion of peripheral blood stem cells in patients with recent anterior myocardial infarction: one-year follow-up of a phase 1 study.
    Santoso T; Irawan C; Alwi I; Aziz A; Kosasih A; Inggriani S; Saputra A; Wintery M; Lison L
    Acta Med Indones; 2011 Apr; 43(2):112-21. PubMed ID: 21785174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of intravenous administration of erythropoietin on the infarct size in primary percutaneous coronary intervention.
    Suh JW; Chung WY; Kim YS; Kim KI; Jeon EJ; Cho YS; Youn TJ; Chae IH; Kim CH; Choi DJ
    Int J Cardiol; 2011 Jun; 149(2):216-220. PubMed ID: 20199815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial effects of diltiazem during myocardial reperfusion: a randomized trial in acute myocardial infarction.
    Pizzetti G; Mailhac A; Li Volsi L; Di Marco F; Lu C; Margonato A; Chierchia SL
    Ital Heart J; 2001 Oct; 2(10):757-65. PubMed ID: 11721720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgM antibodies against apoptotic cells and phosphorylcholine in patients with acute myocardial infarction in relation to infarct size and inflammatory response.
    Diepenhorst GM; Ciurana CL; Diaz Padilla N; Boekholdt SM; Krijnen PA; Lagrand WK; Niessen HW; Hack CE
    Adv Clin Exp Med; 2012; 21(4):455-67. PubMed ID: 23240451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of receipt of chronic statin therapy before the onset of acute myocardial infarction: a retrospective study in patients undergoing primary percutaneous coronary intervention.
    Ishii H; Ichimiya S; Kanashiro M; Aoyama T; Ogawa Y; Murakami R; Amano T; Naruse K; Matsubara T; Murohara T
    Clin Ther; 2006 Nov; 28(11):1812-9. PubMed ID: 17213001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: results of the Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute Myocardial Infarction study (REPAIR-AMI) cardiac magnetic resonance imaging substudy.
    Dill T; Schächinger V; Rolf A; Möllmann S; Thiele H; Tillmanns H; Assmus B; Dimmeler S; Zeiher AM; Hamm C
    Am Heart J; 2009 Mar; 157(3):541-7. PubMed ID: 19249426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute Myocardial Infarction with Hyperoxemic Therapy (AMIHOT): a prospective, randomized trial of intracoronary hyperoxemic reperfusion after percutaneous coronary intervention.
    O'Neill WW; Martin JL; Dixon SR; Bartorelli AL; Trabattoni D; Oemrawsingh PV; Atsma DE; Chang M; Marquardt W; Oh JK; Krucoff MW; Gibbons RJ; Spears JR;
    J Am Coll Cardiol; 2007 Jul; 50(5):397-405. PubMed ID: 17662390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-dose intravenous administration of recombinant human erythropoietin is a promising treatment for patients with acute myocardial infarction - randomized controlled pilot trial of EPO/AMI-1 study -.
    Ozawa T; Toba K; Suzuki H; Kato K; Iso Y; Akutsu Y; Kobayashi Y; Takeyama Y; Kobayashi N; Yoshimura N; Akazawa K; Aizawa Y;
    Circ J; 2010 Jul; 74(7):1415-23. PubMed ID: 20501957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of different clinical pathways on outcomes of patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: the RAPID-AMI study.
    Zhang Q; Zhang RY; Qiu JP; Jin HG; Zhang JF; Wang XL; Jiang L; Liao ML; Hu J; Ding FH; Zhang JS; Shen WF
    Chin Med J (Engl); 2009 Mar; 122(6):636-42. PubMed ID: 19323926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoietin treatment in patients with acute myocardial infarction: a meta-analysis of randomized controlled trials.
    Gao D; Ning N; Niu X; Dang Y; Dong X; Wei J; Zhu C
    Am Heart J; 2012 Nov; 164(5):715-727.e1. PubMed ID: 23137502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Direct percutaneous transluminal coronary angioplasty in patients with acute myocardial infarct treated at the Cardiac Center of the General Medical School Hospital in Prague: a 1-year retrospective study].
    Holm F; Kovárník T; Aschermann M; Simek S; Linhart A; Humhal J; Skulec R; Reznícek V
    Vnitr Lek; 2002 May; 48(5):373-9. PubMed ID: 12061202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.